CD5 and neoplasm: CD5KO anti-CD5 CAR-T cells showed robust cytotoxicity against CD5+ tumor cell lines at the indicated effector to target ratios, whereas they were not cytotoxic against the CD5− cell lines CCRF-CD5KO, K562, and Raji (Figure 4F), demonstrating that the cytolysis was CD5 specific.